Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
Agency: National Institutes of Health
Assistance Listings: 93.279 -- Drug Use and Addiction Research Programs
Last Updated: May 13, 2025
Description
The National Institute on Drug Abuse (NIDA) intends to publish a Notice of Funding Opportunity (NOFO) to support research on the discovery and development of interventions to prevent and treat substance use disorders (SUDs) and overdose. This includes preclinical and clinical research studies that will have high impact and quickly yield the necessary results to advance candidate interventions closer to regulatory approval or clinical adoption. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the UG3/UH3 activity code. Investigators with expertise and insights in the areas of SUD therapeutics discovery and development are encouraged to begin to consider applying for this new NOFO. Collaborative investigations combining expertise in pharmacology, toxicology, medicinal chemistry, neuromodulation, digital interventions, clinical trials, regulatory science, among others, will be encouraged, and these investigators should also begin considering applying for this application.
Eligibility
Eligible applicants
Business
- For-profit organizations other than small businesses
- Small businesses
Government
- Federally recognized Native American tribal governments
- County governments
- Public and Indian housing authorities
- State governments
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Additional information
Grantor contact information
Description
drew.townsend@nih.gov
Documents
No documents are currently available here
Link to additional information
--
Forecasted
Estimated Post Date:
August 15, 2025
Estimated Application Due Date:
October 16, 2025
Estimated Due Date Description:
Not available
Estimated Award Date:
July 1, 2026
Estimated Project Start Date:
July 1, 2026
Fiscal Year:
2026
Award
$--
Program Funding
--
Expected awards
$--
Award Floor
$--
Award Ceiling
Funding opportunity number:
FOR-DA-26-004
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
1
Posted date:
May 13, 2025
Archive date:
--